Kirsty Le Doare Selected Research

Hearing Loss (Hearing Impairment)

1/2023

Neonatal outcomes and indirect consequences following maternal SARS-CoV-2 infection in pregnancy: a systematic review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kirsty Le Doare Research Topics

Disease

8	Stillbirth 01/2023 - 11/2017
7	Infections 03/2024 - 08/2013
7	COVID-19 01/2024 - 01/2022
6	Premature Birth (Birth, Premature) 01/2023 - 11/2017
2	Whooping Cough (Pertussis) 12/2023 - 01/2023
2	Fever (Fevers) 12/2023 - 10/2023
2	Late Onset Disorders 10/2023 - 12/2019
2	Pneumonia (Pneumonitis) 01/2023 - 01/2023
2	Sepsis (Septicemia) 01/2023 - 12/2020
2	Perinatal Death 01/2023 - 01/2021
2	Brain Injuries (Brain Injury) 01/2023 - 01/2022
2	Communicable Diseases (Infectious Diseases) 01/2021 - 03/2015
2	Birth Weight (Birth Weights) 01/2021 - 01/2013
2	Infectious Pregnancy Complications 12/2019 - 01/2019
2	Diseases Newborn Infant 02/2019 - 11/2017
2	HIV Infections (HIV Infection) 01/2016 - 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Human Influenza (Influenza) 03/2024
1	Smallpox (Variola) 02/2024
1	Cytokine Release Syndrome 12/2023
1	Meningitis 11/2023
1	Enterocolitis 01/2023
1	Hearing Loss (Hearing Impairment) 01/2023
1	Obesity 01/2023
1	Critical Illness (Critically Ill) 01/2022
1	Postpartum Hemorrhage 01/2022
1	Diabetes Mellitus 01/2022
1	Confusion (Bewilderment) 05/2021
1	Pregnancy Complications 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2021
1	Urinary Tract Infections (Urinary Tract Infection) 12/2020
1	Lymphopenia (Lymphocytopenia) 08/2020
1	Anemia 01/2018
1	Brain Diseases (Brain Disorder) 11/2017
1	Infant Death 11/2017
1	Neonatal Sepsis 11/2017
1	Bacterial Infections (Bacterial Infection) 09/2015
1	Miliary Tuberculosis 01/2013
1	Tuberculosis (Tuberculoses) 01/2013

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 03/2024 - 11/2017
7	Anti-Bacterial Agents (Antibiotics)IBA 03/2024 - 08/2013
3	AntibodiesIBA 01/2024 - 01/2023
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2016
1	Antiviral Agents (Antivirals)IBA 02/2024
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 02/2024
1	Streptococcal VaccinesIBA 01/2024
1	Immunoglobulin A (IgA)IBA 12/2023
1	CytokinesIBA 12/2023
1	DNA (Deoxyribonucleic Acid)IBA 12/2023
1	BoostrixIBA 01/2023
1	AntigensIBA 01/2023
1	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 01/2023
1	mRNA VaccinesIBA 10/2022
1	Messenger RNA (mRNA)IBA 10/2022
1	COVID-19 VaccinesIBA 01/2022
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022
1	mesoglycanIBA 01/2021
1	Transaminases (Aminotransferases)IBA 08/2020
1	ProcalcitoninIBA 08/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Complement C3b (C3bi)IBA 01/2015
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2013

Therapy/Procedure

5	Critical Care (Surgical Intensive Care) 03/2024 - 01/2022
4	Antibiotic Prophylaxis 10/2023 - 11/2017
2	Therapeutics 02/2024 - 09/2015
2	Cesarean Section (Caesarean Section) 01/2023 - 01/2021
1	Drug Therapy (Chemotherapy) 03/2024
1	Operative Surgical Procedures 03/2024
1	Feeding Methods 01/2023
1	Artificial Respiration (Mechanical Ventilation) 01/2023
1	Induced Hypothermia 01/2022